Kenneth Ott
8 Papers
67 Citations
Kenneth Ott is an academic researcher. The author has contributed to research in topics: Prognostic variable & Brain metastasis. The author has an hindex of 6, co-authored 8 publications.
Chat about Author
Papers
Survival Patterns of 5750 Stereotactic Radiosurgery-Treated Patients with Brain Metastasis as a Function of the Number of Lesions.
Mir Amaan Ali,Brian R. Hirshman,Bayard Wilson,Kate T. Carroll,James A. Proudfoot,Steven J. Goetsch,John F. Alksne,Kenneth Ott,Hitoshi Aiyama,Osamu Nagano,Bob S. Carter,Gerald Fogarty,Angela Hong,Toru Serizawa,Masaaki Yamamoto,Clark C. Chen,Clark C. Chen +16 more
TL;DR: The contribution of BM number to overall survival is modest and should be considered as one of the many variables considered in the decision between SRS and whole-brain radiation therapy.
41
Stereotactic Radiosurgery Treatment of Trigeminal Neuralgia: Clinical Outcomes and Prognostic Factors.
Zachary J. Taich,Steven J. Goetsch,Elsa Monaco,Bob S. Carter,Kenneth Ott,John F. Alksne,Clark C. Chen +6 more
TL;DR: Excellent TN pain relief was achieved with the delivery of 85 Gy in a single-shot, 4-mm isocenter SRS targeting the dorsal root entry zone and SRS is efficacious in patients with classical TN despite concurrent diagnosis of MS.
33
Retained intracranial metallic foreign bodies. Report of two cases.
TL;DR: The authors discuss two examples of extensive migration of retained metallic foreign bodies and the potential for further neurological injury from migration, formation of neurotoxic breakdown products, and the danger of infection.
30
Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
Mir Amaan Ali,Brian R. Hirshman,Bayard Wilson,Alexander J. Schupper,Rushikesh S. Joshi,James A. Proudfoot,Steven J. Goetsch,John F. Alksne,Kenneth Ott,Hitoshi Aiyama,Osamu Nagano,Bob S. Carter,Veronica Chiang,Toru Serizawa,Masaaki Yamamoto,Clark C. Chen +15 more
TL;DR: The prognostic value of the ds-GPA scale for RCC brain metastasis was enhanced by the incorporation of CITV and this finding was validated in an independent cohort of 107 SRS-treated RCC BM patients.
26
Prognostic factors for stereotactic radiosurgery-treated patients with cerebral metastasis: implications on randomised control trial design and inter-institutional collaboration.
David D. Gonda,Teddy E. Kim,Steven J. Goetsch,Takuya Kawabe,Shinya Watanabe,John F. Alksne,J.A. Hattangadi,Masayuki Nitta,Kenneth Ott,David W. Hodgens,Bob S. Carter,Masaaki Yamamoto,Clark C. Chen +12 more
TL;DR: This first integrated study that defined prognostic factors for SRS-treated patients with cerebral metastases using an inter-institutional validation study design establishes a model for collaborative interactions between large volume centers and provides prognostic variables that should be incorporated into future clinical trial design.
25